• About us
• Contact

Advertisement

Organisation › Details

Remiges Ventures

Based in Seattle and Tokyo, Remiges Ventures is a US-Japan cross-border venture capital firm focused on therapeutics. Remiges Ventures takes a lead position for the syndication of Series A or later stage of investment rounds globally and actively creates new companies based on innovative assets discovered at Japanese academic institutions. Remiges Ventures’ team is connected with serial entrepreneurs, KOLs in various therapeutic areas, key consultants and major large pharmaceutical companies in the globe. The team actively participates in the value creation for its portfolio companies. *

 

	Start	2017-06-27 existent
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Nonomura, Kazuhika (Remiges Ventures 202209 Principal)
	City	n. a.
		Address record changed: 2022-08-10
Basic data	Employees	n. a.
		* Document for »About Section«: Glycomine, Inc.. (12/17/21). "Press Release: Glycomine Closes $68 Million Series B to Advance into Clinical Trials a Novel Treatment for PMM2-CDG, a Rare Glycosylation Disease". San Carlos, CA.
		Record changed: 2022-09-26

Advertisement

More documents for Remiges Ventures

• [1] Kupando GmbH. (9/26/22). "Press Release: Kupando Raises €13 Million in Series A Funding Round". Schönefeld....
• [2] Mitoconix Bio Ltd.. (6/27/17). "Press Release: Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies". Ness Ziona....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.